HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicationRequest
Resource MedicationRequest "medication-request-example-tucatinib"
Profile: Cancer-Related Medication Request
status: active
intent: order
medication: tucatinib 150 MG Oral Tablet (RxNorm#2361290)
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
authoredOn: 2020-03-12
requester: Practitioner/PractitionerExample1 " ANYDOC"
reasonReference: Condition/KaitlynPrimaryCancerConditionEx1
dosageInstruction
text: oral twice a day every day
timing: Starting 2020-04-01, Once
route: Oral route (qualifier value) (SNOMED CT#26643006)
doseAndRate
maxDosePerAdministration: 2